Abstract: The present invention provides a novel, isolated anti-CXCR4 antibody for use in the diagnosis of cancer. In particular, the antibody of the invention recognizes monomeric and homodimeric CXCR4, but not heterodimeric CXCR4.
Type:
Grant
Filed:
July 30, 2012
Date of Patent:
December 13, 2016
Assignee:
Pierrre Fabre Medicament
Inventors:
Christine Klinguer-Hamour, Alexandra Jouhanneaud, Marie-Claire Janin-Bussat